• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项随机对照研究,比较促性腺激素释放激素激动剂预处理后静脉注射脉冲式促性腺激素释放激素与克罗米芬对多囊卵巢综合征患者的内分泌影响。

A randomized controlled study comparing the endocrine effects of pulsatile intravenous gonadotropin-releasing hormone after gonadotropin-releasing hormone agonist pretreatment versus clomiphene citrate in patients with polycystic ovary syndrome.

作者信息

Timmerman-van Kessel E C, Cikot R J, Dargel-Donkers E J, Zwertbroek W, van Dop P A, Schoot D C

机构信息

Catharina Hospital, Eindhoven, The Netherlands.

出版信息

Fertil Steril. 2000 Jun;73(6):1145-8. doi: 10.1016/s0015-0282(00)00535-5.

DOI:10.1016/s0015-0282(00)00535-5
PMID:10856472
Abstract

OBJECTIVE

To compare the endocrine changes in the follicular phase in infertile patients with polycystic ovary syndrome (PCOS) treated with either pulsatile IV GnRH after GnRH-agonist (GnRH-a) down-regulation or clomiphene citrate (CC).

DESIGN

Subgroup analysis within a randomized, controlled, multicenter study.

SETTING

Women referred to the Infertility Clinic, Catharina Hospital Eindhoven, The Netherlands.

PATIENT(S): Twenty-eight infertile patients with PCOS. INTERVENTIONs): Patients were randomly assigned to pulsatile IV GnRH (10-20 microgram/90 min) after GnRH-a down-regulation or CC (50-150 mg; cycle days 3-7). Patients were monitored on alternate days with ovarian sonography and serum concentrations of E(2), LH, and FSH. Serum P and sonography confirmed ovulation.

MAIN OUTCOME MEASURE(S): Serum concentrations of E(2), LH, and FSH were assessed before treatment was started and after each ovarian sonography.

RESULT(S): In ovulatory cycles, no statistically significant differences were observed during the follicular phase comparing serum concentrations of E(2), LH, and FSH between the treatments. However, a significant increase in LH occurred in the GnRH group.

CONCLUSION(S): No significant endocrine differences were observed between GnRH and CC treatment. However, there was a significant increase in the serum LH concentration during the follicular phase in the GnRH group. Increments of LH in the GnRH group may be due to recovery of endogenous LH secretion.

摘要

目的

比较多囊卵巢综合征(PCOS)不孕患者在GnRH激动剂(GnRH-a)降调节后接受脉冲式静脉注射GnRH治疗或克罗米芬(CC)治疗时卵泡期的内分泌变化。

设计

一项随机对照多中心研究中的亚组分析。

地点

荷兰埃因霍温卡塔琳娜医院不孕门诊。

患者

28例PCOS不孕患者。

干预措施

患者被随机分配至GnRH-a降调节后接受脉冲式静脉注射GnRH(10 - 20微克/90分钟)或CC(50 - 150毫克;月经周期第3 - 7天)治疗。隔天通过卵巢超声检查以及检测血清E(2)、LH和FSH浓度对患者进行监测。血清P及超声检查确认排卵情况。

主要观察指标

在开始治疗前以及每次卵巢超声检查后评估血清E(2)、LH和FSH浓度。

结果

在排卵周期中,卵泡期比较两种治疗方法的血清E(2)、LH和FSH浓度时,未观察到统计学上的显著差异。然而,GnRH组的LH出现显著升高。

结论

GnRH治疗与CC治疗之间未观察到显著的内分泌差异。然而,GnRH组在卵泡期血清LH浓度显著升高。GnRH组LH的升高可能是由于内源性LH分泌的恢复。

相似文献

1
A randomized controlled study comparing the endocrine effects of pulsatile intravenous gonadotropin-releasing hormone after gonadotropin-releasing hormone agonist pretreatment versus clomiphene citrate in patients with polycystic ovary syndrome.一项随机对照研究,比较促性腺激素释放激素激动剂预处理后静脉注射脉冲式促性腺激素释放激素与克罗米芬对多囊卵巢综合征患者的内分泌影响。
Fertil Steril. 2000 Jun;73(6):1145-8. doi: 10.1016/s0015-0282(00)00535-5.
2
Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome.持续性生理性脉冲式促性腺激素释放激素疗法对多囊卵巢综合征女性的益处。
Fertil Steril. 1994 Jun;61(6):1027-33.
3
Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.枸橼酸氯米酚在 GnRH 激动剂扳机后对黄体期的影响。
Reprod Biomed Online. 2014 Mar;28(3):359-68. doi: 10.1016/j.rbmo.2013.10.019. Epub 2013 Oct 31.
4
Comparison of the effects of ovarian cauterization and gonadotropin-releasing hormone agonist and oral contraceptive therapy combination on endocrine changes in women with polycystic ovary disease.卵巢烧灼术与促性腺激素释放激素激动剂及口服避孕药联合治疗对多囊卵巢疾病女性内分泌变化影响的比较
Fertil Steril. 1996 Jun;65(6):1115-8. doi: 10.1016/s0015-0282(16)58323-x.
5
Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.特定因素可预测多囊卵巢综合征患者对脉冲式促性腺激素释放激素治疗的反应。
J Clin Endocrinol Metab. 2001 Jun;86(6):2428-36. doi: 10.1210/jcem.86.6.7538.
6
Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.多囊卵巢综合征患者中对枸橼酸氯米芬有反应者的卵巢和子宫动脉血流变化:与血清激素浓度的相关性
Ultrasound Obstet Gynecol. 1998 Sep;12(3):188-96. doi: 10.1046/j.1469-0705.1998.12030188.x.
7
Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.内分泌反应决定了不同排卵障碍中脉冲式促性腺激素释放激素诱导排卵的临床结局。
J Clin Endocrinol Metab. 1991 May;72(5):965-72. doi: 10.1210/jcem-72-5-965.
8
Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.皮下注射脉冲式促性腺激素释放激素可降低多囊卵巢综合征女性的血清促卵泡生成素和黄体生成素水平:一项初步研究。
Fertil Steril. 2005 May;83(5):1466-72. doi: 10.1016/j.fertnstert.2004.11.046.
9
Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome.多囊卵巢综合征女性下丘脑-垂体-卵巢对枸橼酸氯米芬的反应
Fertil Steril. 1993 Mar;59(3):532-8.
10
Exploring the recovery phase after treatment with a gonadotrophin-releasing hormone-agonist for ovulation induction in polycystic ovary syndrome: three pilot trials.
Eur J Obstet Gynecol Reprod Biol. 1995 Oct;62(2):221-4. doi: 10.1016/0301-2115(95)02182-7.

引用本文的文献

1
Pulsatile gonadotrophin releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome.用于多囊卵巢综合征相关不孕症促排卵的脉冲式促性腺激素释放激素
Cochrane Database Syst Rev. 2004;2003(1):CD000412. doi: 10.1002/14651858.CD000412.pub2.